Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma
Science Advances · 26.06.2026 · 12 (26)
DOI: 10.1126/sciadv.aec7215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 26.06.2026. Verfasst von Giorgia Nasi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, Immunotherapy, Intraepithelial Lymphocytes. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FWF, GammaDelta Therapeutics Ltd and Takeda Pharmaceutical, Center for tumor biology and immunology (CTBI), University of Salzburg.
Abstract (Originalsprache)
Gamma delta (γδ) T cells are critical for tissue immune surveillance and their presence in tumors correlates with a favorable prognosis, highlighting their therapeutic potential. Although γδ T cells are abundant in the skin, their therapeutic value in skin cancer has remained largely unexplored due to challenges in isolating sufficient numbers of γδ T cells from human tissues and a lack of suitable preclinical models for skin cancer. Here, we are using innovative methods to expand human cutaneous γδ T cells ex vivo, enabling us to investigate their therapeutic potential in a human cutaneous squamous cell carcinoma (cSCC) mouse model. In this model, γδ T cells were specifically recruited to and maintained in the cSCC xenograft. These tumor-infiltrating cells exhibited an activated, cytotoxic phenotype and demonstrated effective antitumor activity in vivo. Collectively, our findings provide preclinical evidence supporting human skin–resident γδ T cells as a promising immunotherapeutic approach for treating skin cancers such as cSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
- Institute of Medical Systems Biology, Johannes Kepler University Linz, Linz, Austria.
- GammaDelta Therapeutics Ltd, London, UK.
- Takeda Pharmaceuticals, Oncology Drug Discovery Unit, Cambridge, MA, USA.
- EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, Salzburg, Austria.
- Department of Dermatology and Venereology, Kepler University Hospital Linz, Linz, Austria.
ORCID-Profile: Giorgia Nasi, Leonie C Schöftner, Amalia Sophianidis, Julia Feiser, Teodora Aleksandrova, Oliver Nussbaumer, Roland Zauner, Johanna Moser-Waxenecker, Suraj R Varkhande, Anshu Sharma, Teresa Burner, Christina Guttmann-Gruber, Iris K Gratz
Förderung
- FWF
- GammaDelta Therapeutics Ltd and Takeda Pharmaceutical
- Center for tumor biology and immunology (CTBI), University of Salzburg
Zitieren
APA
Nasi, G., Schöftner, L. C., Ronacher, L., Sophianidis, A., Feiser, J., Aleksandrova, T., Nussbaumer, O., Hutton, A., Zauner, R., Moser-Waxenecker, J., Varkhande, S. R., Sharma, A., Ettinger, M., Burner, T., Laimer, M., Guttmann-Gruber, C., & Gratz, I. K. (2026). Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma. Science Advances, 12(26). https://doi.org/10.1126/sciadv.aec7215
Vancouver
Nasi G, Schöftner LC, Ronacher L, Sophianidis A, Feiser J, Aleksandrova T, et al. Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma. Science Advances. 2026;12(26). doi:10.1126/sciadv.aec7215
BibTeX
@article{Nasi2026,
author = {Nasi, Giorgia and Schöftner, Leonie C and Ronacher, Lara and Sophianidis, Amalia and Feiser, Julia and Aleksandrova, Teodora and Nussbaumer, Oliver and Hutton, Andrew and Zauner, Roland and Moser-Waxenecker, Johanna and Varkhande, Suraj R and Sharma, Anshu and Ettinger, Monika and Burner, Teresa and Laimer, Martin and Guttmann-Gruber, Christina and Gratz, Iris K},
title = {Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {26},
doi = {10.1126/sciadv.aec7215}
}
EUVIMED